Hepatitis C Medications
Approved Medications
- An Overview of Ribavirin (Virazol, Rebetol, Copegus) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
- Both Hepatitis C Drugs Work About the Same: Study (August 11, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
- An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (January 10, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (January 4, 2005)
To read PDF, click here
From U.S. National Institutes of Health
- New Hepatitis C Treatment Options Available (September 20, 2004)
Updates on generic ribavirin and the approval of two forms of peg-interferon.
To read PDF, click here
From PositiveWords
- Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Hepatitis C and Complementary and Alternative Medicine: 2003 Update (May 2004)
[Archived Article]
To read PDF, click here
From U.S. National Center for Complementary and Alternative Medicine
- HCV Treatment and Monitoring Guide (August 2003)
[Archived Article]
A basic guide to hepatitis C medications.
To read PDF, click here
In WISE Words, from Project Inform
- The Management of Adverse Effects with PEG-Interferon/Ribavirin Combination Therapy is a Significant Challenge (March 2003)
[Archived Article]
To read PDF, click here
From HCV Advocate
- FDA Approves Pegasys for Hepatitis C (October 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Study: Hepatitis Shots Show Promise (September 26, 2002)
[Archived Article]
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Why Interferon Induction Therapy Has Been a Failure (April 2002)
[Archived Article]
To read PDF, click here
From HCV Advocate
- Important Drug Warning: Intron A (PDF) (December 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Novel Treatments for HCV (October 21, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- Hepatitis C: Progress Beyond Interferon (October 19, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
- FDA Approves Peg-Interferon and Ribavirin Treatment Combination (September 21, 2001)
[Archived Article]
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project
- Important Drug Warning: Roferon-A (PDF) (September 2001)
[Archived Article]
From U.S. Food and Drug Administration
- FDA Approves Stand-Alone Package of Rebetol (Ribavirin) for Combination Therapy With Intron A for the Treatment of Chronic Hepatitis C Infection (July 26, 2001)
[Archived Article]
See also Rebetol (Ribavirin) Product Information (2001) (PDF).
From U.S. Food and Drug Administration
- Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
[Archived Article]
From U.S. Food and Drug Administration
- Peg-Interferon-Alfa Approved for Hepatitis C (March 2001)
[Archived Article]
In What's New, from Project Inform
- Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
[Archived Article]
From U.S. Food and Drug Administration
- New Drugs in Development: Pegylated Interferons for the Treatment of Hepatitis C (Summer 2000)
[Archived Article]
To read PDF, click here
In CRIA Update, from AIDS Community Research Initiative of America
- Evolving Strategies to Attack Hepatitis C (December 1998)
[Archived Article]
New treatment combinations are highly toxic but have substantial success rates.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Hepatitis C: New Treatment Overview (September 4, 1998)
[Archived Article]
From AIDS Treatment News
- Can Science Meet the Challenges of the HCV Pandemic? (July 1998)
[Archived Article]
New treatment options for chronic Hepatitis C.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Ribavirin Approved for Hepatitis C Combination Treatment (June 22, 1998)
[Archived Article]
From AIDS Treatment News
- Hepatitis C -- Important Treatment Advance (May 15, 1998)
[Archived Article]
An interview with Douglas Dieterich, M.D.
In AIDS Treatment News, from AIDS Treatment News
- Hepatitis C and HIV: Ribavirin Plus Interferon Study Recruiting (May 15, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
- Alright Thymosin! (April 1996)
[Archived Article]
In Notes From the Underground, from PWA Health Group
Drug Pricing
|
|
Advertisement
|
E-Mail
Glossary
Share
